Related Articles
Increased FoxM1 expression is a target for metformin in the suppression of EMT in prostate cancer
Metformin inhibits TGF‑β1‑induced epithelial‑mesenchymal transition and liver metastasis of pancreatic cancer cells
Hispidulin modulates epithelial‑mesenchymal transition in breast cancer cells
Metformin inhibits epithelial‑mesenchymal transition of oral squamous cell carcinoma via the mTOR/HIF‑1α/PKM2/STAT3 pathway
HDAC inhibitors induce epithelial-mesenchymal transition in colon carcinoma cells